Monthly
US$200
Billed every month
Sign in to subscribeRosuvastatin Calcium Tablets
As of 13 November 2026, for Rosuvastatin Calcium Tablets, 18 applications are listed as under review at China's CDE; 6 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 35 holders.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 5 applicationsSupplement delivery: 3 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders35View records ↓
Under-review filings18View records ↓
This year’s generic filers6View records ↓
NHSA approval numbers64View records ↓
API companies with A status31View records ↓
Chemical-drug catalogue
Loaded records: 35 holders; 6 in the quality-and-efficacy consistency-evaluation category, and 28 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Ling Yao Bio Technology (Shanghai) Co., Ltd. romanized | Jiangsu Fu Dan Fu Hua Pharma Co., Ltd. romanized | 国药准字H20263143 | 2026/01/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Rui Yang Pharmaceutical Co., Ltd. romanized | Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20269013 | 2026/01/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| YaoPharma Co., Ltd. | YaoPharma Co., Ltd. | 国药准字H20255893 | 2025/11/12 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| YaoPharma Co., Ltd. | YaoPharma Co., Ltd. | 国药准字H20255892 | 2025/11/12 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20247200 | 2024/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Heng Rui Pharmaceutical Co., Ltd. romanized | Chengdu Heng Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244465 | 2024/07/16 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanxi Lan Hua Pharma Co., Ltd. romanized | Shanxi Lan Hua Pharma Co., Ltd. romanized | 国药准字H20237182 | 2023/12/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20234598 | 2023/12/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Tian Heng Pharma Co., Ltd. romanized | Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | 国药准字H20234183 | 2023/09/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Tian Heng Pharma Co., Ltd. romanized | Beijing Tian Heng Drug Research Institute Nan Yang Tian Heng Pharmaceutical Factory romanized | 国药准字H20234184 | 2023/09/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20233778 | 2023/06/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | 2023/05/12 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20233495 | 2023/04/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20233494 | 2023/04/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | 2022/07/07 | 10mg | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20227079 | 2022/06/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Topfond Pharmaceutical Co., Ltd. | Topfond Pharmaceutical Co., Ltd. | 国药准字H20223159 | 2022/03/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Rui Yang Pharmaceutical Co., Ltd. romanized | Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | 2022/03/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Topfond Pharmaceutical Co., Ltd. | Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | 2022/03/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Lukang Pharmaceutical Co.,Ltd. | Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213943 | 2021/12/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20213616 | 2021/07/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20213615 | 2021/07/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213617 | 2021/07/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Jiudian Pharmaceutical Co., Ltd | Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | 2021/07/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20213421 | 2021/05/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20213422 | 2021/05/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shanxi Lan Hua Pharma Co., Ltd. romanized | Shanxi Lan Hua Pharma Co., Ltd. romanized | 国药准字H20213121 | 2021/02/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Fujian Dong Rui Pharmaceutical Co., Ltd. romanized | Fujian Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20213006 | 2021/01/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20203657 | 2020/12/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20203658 | 2020/12/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20203569 | 2020/11/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20203568 | 2020/11/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | 2020/09/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203480 | 2020/09/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203479 | 2020/09/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203478 | 2020/09/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20203475 | 2020/09/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | 2020/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203463 | 2020/09/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | 2020/08/17 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080669 | 2020/08/10 | 5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hefei He Yuan Pharma Co., Ltd. romanized | Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20203395 | 2020/08/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei He Yuan Pharma Co., Ltd. romanized | Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20203396 | 2020/08/05 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Mei Luo Pharma Co., Ltd. romanized | A Si Li Kang Pharma (Zhongguo) Co., Ltd. romanized | 国药准字H20203224 | 2020/05/26 | 10mg | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Mei Luo Pharma Co., Ltd. romanized | A Si Li Kang Pharma (Zhongguo) Co., Ltd. romanized | 国药准字H20203223 | 2020/05/26 | 5mg | Generic approved under the new chemical-drug registration classification | CDE |
| Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | 2020/03/03 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | 2020/02/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Lek Pharmaceuticals d.d. | Lek Pharmaceuticals d.d. | H20180007 | 2019/04/03 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Lek Pharmaceuticals d.d. | Lek Pharmaceuticals d.d. | H20180008 | 2019/04/03 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Name not romanized | Nanjing Xian Sheng Dong Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H20113265 | 2019/03/05 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080241 | 2019/02/02 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080240 | 2019/02/02 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hai Zheng Hui Rui Pharmaceutical Co., Ltd. romanized | Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20143338 | — | 10mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Hai Zheng Hui Rui Pharmaceutical Co., Ltd. romanized | Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20143337 | — | 5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Name not romanized | Nanjing Xian Sheng Dong Yuan Pharmaceutical Co., Ltd. romanized | 国药准字H20113246 | 2018/10/08 | See source | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Name not romanized | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | 2018/02/09 | 10mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Name not romanized | ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | 2018/02/09 | 5mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | 2017/12/27 | 10mg | Drug that passed quality-and-efficacy consistency evaluation | CDE |
| Astrazeneca UK Limited | IPR Pharmaceuticals,INCORPORATED | H20160546 | 2006/12/27 | 5mg | Imported originator drug | CDE |
| Astrazeneca UK Limited | IPR Pharmaceuticals,INCORPORATED | H20160545 | 2006/12/27 | 10mg | Imported originator drug | CDE |
| Astrazeneca UK Limited | IPR Pharmaceuticals,INCORPORATED | H20160611 | 2006/12/27 | 20mg | Imported originator drug | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 64 distinct approval numbers and 37 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | See source | Category B | XC10AAR069A001010100177 | NHSA |
| YaoPharma Co., Ltd. | 国药准字H20255892 | See source | Category B | XC10AAR069A001010101066 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203478 | See source | Category B | XC10AAR069A001010101397 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001010101503 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113246 | See source | Category B | XC10AAR069A001010101594 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | See source | Category B | XC10AAR069A001010101606 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001010101631 | NHSA |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20234598 | See source | Category B | XC10AAR069A001010101650 | NHSA |
| Chengdu Heng Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244465 | See source | Category B | XC10AAR069A001010102031 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001010102763 | NHSA |
| Shanxi Lan Hua Pharma Co., Ltd. romanized | 国药准字H20213121 | See source | Category B | XC10AAR069A001010102909 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | See source | Category B | XC10AAR069A001010102968 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001010103006 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223159 | See source | Category B | XC10AAR069A001010103098 | NHSA |
| Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20203475 | See source | Category B | XC10AAR069A001010103865 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080241 | See source | Category B | XC10AAR069A001010104010 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20203568 | See source | Category B | XC10AAR069A001010104043 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001010104152 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213615 | See source | Category B | XC10AAR069A001010104565 | NHSA |
| Han Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20143338 | 10mg | Category B | XC10AAR069A001010104641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001010104658 | NHSA |
| Fujian Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20213006 | See source | Category B | XC10AAR069A001010104876 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001010104942 | NHSA |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20203657 | See source | Category B | XC10AAR069A001010106988 | NHSA |
| Anhui Jie Xi Pharmaceuticals Co., Ltd. romanized | 国药准字H20203395 | See source | Category B | XC10AAR069A001010109541 | NHSA |
| Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized | 国药准字H20234321 | See source | Category B | XC10AAR069A001010109563 | NHSA |
| Lek Pharmaceuticals d.d. | 国药准字J20190009 | See source | Category B | XC10AAR069A001010109659 | NHSA |
| Astrazeneca UK limited | 国药准字HJ20160546 | See source | Category B | XC10AAR069A001010178241 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203463 | See source | Category B | XC10AAR069A001010179303 | NHSA |
| Lek Pharmaceuticals d.d. | 国药准字HJ20180008 | See source | Category B | XC10AAR069A001010179428 | NHSA |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20233494 | See source | Category B | XC10AAR069A001010180086 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001010180698 | NHSA |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20213421 | See source | Category B | XC10AAR069A001010181288 | NHSA |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20233778 | See source | Category B | XC10AAR069A001010182919 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213943 | See source | Category B | XC10AAR069A001010183198 | NHSA |
| Ling Yao Bio Technology (Shanghai) Co., Ltd. romanized | 国药准字H20263143 | See source | Category B | XC10AAR069A001010183356 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | See source | Category B | XC10AAR069A001010200177 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203478 | See source | Category B | XC10AAR069A001010201397 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001010201503 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113246 | See source | Category B | XC10AAR069A001010201594 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | See source | Category B | XC10AAR069A001010201606 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001010201631 | NHSA |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20234598 | See source | Category B | XC10AAR069A001010201650 | NHSA |
| Chengdu Heng Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244465 | See source | Category B | XC10AAR069A001010202031 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001010202763 | NHSA |
| Shanxi Lan Hua Pharma Co., Ltd. romanized | 国药准字H20213121 | See source | Category B | XC10AAR069A001010202909 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | See source | Category B | XC10AAR069A001010202968 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001010203006 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223159 | See source | Category B | XC10AAR069A001010203098 | NHSA |
| Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20203475 | See source | Category B | XC10AAR069A001010203865 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080241 | See source | Category B | XC10AAR069A001010204010 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20203568 | See source | Category B | XC10AAR069A001010204043 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001010204152 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213615 | See source | Category B | XC10AAR069A001010204565 | NHSA |
| Han Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20143338 | 10mg | Category B | XC10AAR069A001010204641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001010204658 | NHSA |
| Fujian Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20213006 | See source | Category B | XC10AAR069A001010204876 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001010204942 | NHSA |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20203658 | See source | Category B | XC10AAR069A001010206988 | NHSA |
| Anhui Jie Xi Pharmaceuticals Co., Ltd. romanized | 国药准字H20203395 | See source | Category B | XC10AAR069A001010209541 | NHSA |
| Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized | 国药准字H20234321 | See source | Category B | XC10AAR069A001010209563 | NHSA |
| Lek Pharmaceuticals d.d. | 国药准字J20190009 | See source | Category B | XC10AAR069A001010209659 | NHSA |
| Astrazeneca UK limited | 国药准字HJ20160546 | See source | Category B | XC10AAR069A001010278241 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203463 | See source | Category B | XC10AAR069A001010279303 | NHSA |
| Lek Pharmaceuticals d.d. | 国药准字HJ20180008 | See source | Category B | XC10AAR069A001010279428 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001010280698 | NHSA |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20213421 | See source | Category B | XC10AAR069A001010281288 | NHSA |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20233778 | See source | Category B | XC10AAR069A001010282919 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213943 | See source | Category B | XC10AAR069A001010283198 | NHSA |
| Ling Yao Bio Technology (Shanghai) Co., Ltd. romanized | 国药准字H20263143 | See source | Category B | XC10AAR069A001010283356 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | See source | Category B | XC10AAR069A001010300177 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203478 | See source | Category B | XC10AAR069A001010301397 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001010301503 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113246 | See source | Category B | XC10AAR069A001010301594 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | See source | Category B | XC10AAR069A001010301606 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001010301631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001010302763 | NHSA |
| Shanxi Lan Hua Pharma Co., Ltd. romanized | 国药准字H20213121 | See source | Category B | XC10AAR069A001010302909 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | See source | Category B | XC10AAR069A001010302968 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001010303006 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223159 | See source | Category B | XC10AAR069A001010303098 | NHSA |
| Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20203475 | See source | Category B | XC10AAR069A001010303865 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080241 | See source | Category B | XC10AAR069A001010304010 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213615 | See source | Category B | XC10AAR069A001010304565 | NHSA |
| Han Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20143338 | 10mg | Category B | XC10AAR069A001010304641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001010304658 | NHSA |
| Fujian Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20213006 | See source | Category B | XC10AAR069A001010304876 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001010304942 | NHSA |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20203658 | See source | Category B | XC10AAR069A001010306988 | NHSA |
| Anhui Jie Xi Pharmaceuticals Co., Ltd. romanized | 国药准字H20203395 | See source | Category B | XC10AAR069A001010309541 | NHSA |
| Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized | 国药准字H20234321 | See source | Category B | XC10AAR069A001010309563 | NHSA |
| Lek Pharmaceuticals d.d. | 国药准字J20190009 | See source | Category B | XC10AAR069A001010309659 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203463 | See source | Category B | XC10AAR069A001010379303 | NHSA |
| Lek Pharmaceuticals d.d. | 国药准字HJ20180008 | See source | Category B | XC10AAR069A001010379428 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001010380698 | NHSA |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20213421 | See source | Category B | XC10AAR069A001010381288 | NHSA |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20233778 | See source | Category B | XC10AAR069A001010382919 | NHSA |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20213943 | See source | Category B | XC10AAR069A001010383198 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | See source | Category B | XC10AAR069A001010400177 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203478 | See source | Category B | XC10AAR069A001010401397 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001010401503 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113246 | See source | Category B | XC10AAR069A001010401594 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | See source | Category B | XC10AAR069A001010401606 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001010401631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001010402763 | NHSA |
| Shanxi Lan Hua Pharma Co., Ltd. romanized | 国药准字H20213121 | See source | Category B | XC10AAR069A001010402909 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | See source | Category B | XC10AAR069A001010402968 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001010403006 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223159 | See source | Category B | XC10AAR069A001010403098 | NHSA |
| Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20203475 | See source | Category B | XC10AAR069A001010403865 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080241 | See source | Category B | XC10AAR069A001010404010 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213615 | See source | Category B | XC10AAR069A001010404565 | NHSA |
| Han Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20143338 | 10mg | Category B | XC10AAR069A001010404641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001010404658 | NHSA |
| Fujian Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20213006 | See source | Category B | XC10AAR069A001010404876 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001010404942 | NHSA |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20203658 | See source | Category B | XC10AAR069A001010406988 | NHSA |
| Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized | 国药准字H20234321 | See source | Category B | XC10AAR069A001010409563 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203463 | See source | Category B | XC10AAR069A001010479303 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001010480698 | NHSA |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20233778 | See source | Category B | XC10AAR069A001010482919 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | See source | Category B | XC10AAR069A001010500177 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203478 | See source | Category B | XC10AAR069A001010501397 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001010501503 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113246 | See source | Category B | XC10AAR069A001010501594 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | See source | Category B | XC10AAR069A001010501606 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001010501631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001010502763 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | See source | Category B | XC10AAR069A001010502968 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001010503006 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223159 | See source | Category B | XC10AAR069A001010503098 | NHSA |
| Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20203475 | See source | Category B | XC10AAR069A001010503865 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001010504658 | NHSA |
| Fujian Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20213006 | See source | Category B | XC10AAR069A001010504876 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001010504942 | NHSA |
| Beijing Jing Feng Pharmaceutical Group Co., Ltd. romanized | 国药准字H20234321 | See source | Category B | XC10AAR069A001010509563 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203463 | See source | Category B | XC10AAR069A001010579303 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001010580698 | NHSA |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20233778 | See source | Category B | XC10AAR069A001010582919 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | See source | Category B | XC10AAR069A001010600177 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001010601503 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113246 | See source | Category B | XC10AAR069A001010601594 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | See source | Category B | XC10AAR069A001010601606 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001010601631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001010602763 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | See source | Category B | XC10AAR069A001010602968 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001010603006 | NHSA |
| Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20203475 | See source | Category B | XC10AAR069A001010603865 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001010604658 | NHSA |
| Fujian Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20213006 | See source | Category B | XC10AAR069A001010604876 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001010604942 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203463 | See source | Category B | XC10AAR069A001010679303 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001010680698 | NHSA |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20233778 | See source | Category B | XC10AAR069A001010682919 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | See source | Category B | XC10AAR069A001010700177 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001010701503 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001010701631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001010702763 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | See source | Category B | XC10AAR069A001010702968 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001010703006 | NHSA |
| Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20203475 | See source | Category B | XC10AAR069A001010703865 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001010704658 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001010704942 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203463 | See source | Category B | XC10AAR069A001010779303 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001010780698 | NHSA |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20233778 | See source | Category B | XC10AAR069A001010782919 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | See source | Category B | XC10AAR069A001010800177 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001010801503 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | See source | Category B | XC10AAR069A001010801606 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001010801631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001010802763 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | See source | Category B | XC10AAR069A001010802968 | NHSA |
| Chi Feng Sai Lin Tai Pharma Co., Ltd. romanized | 国药准字H20203475 | See source | Category B | XC10AAR069A001010803865 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001010804658 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001010804942 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203463 | See source | Category B | XC10AAR069A001010879303 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001010880698 | NHSA |
| Le Pu Pharmaceutical Technology Co., Ltd. romanized | 国药准字H20233778 | See source | Category B | XC10AAR069A001010882919 | NHSA |
| Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | See source | Category B | XC10AAR069A001010900177 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001010901503 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | See source | Category B | XC10AAR069A001010901606 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001010901631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001010902763 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001010904942 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203463 | See source | Category B | XC10AAR069A001010979303 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001010980698 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001011001503 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001011001631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001011002763 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001011004942 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001011080698 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001011101503 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001011101631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001011102763 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001011104942 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001011180698 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20203501 | See source | Category B | XC10AAR069A001011201503 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001011201631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001011202763 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001011204942 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001011280698 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001011301631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001011302763 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001011380698 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001011401631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001011402763 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001011480698 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001011501631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001011502763 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001011580698 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001011601631 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20203427 | See source | Category B | XC10AAR069A001011602763 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001011680698 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001011701631 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001011780698 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001011801631 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001011880698 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001011901631 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001011980698 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001012001631 | NHSA |
| Hefei Ying Tai Pharmaceutical Co., Ltd. romanized | 国药准字H20203049 | See source | Category B | XC10AAR069A001012080698 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001012101631 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001012201631 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001012301631 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001012401631 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001012501631 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001012601631 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001012701631 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001012801631 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001012901631 | NHSA |
| Jiangsu Yue Xing Pharma Co., Ltd. romanized | 国药准字H20223483 | See source | Category B | XC10AAR069A001013001631 | NHSA |
| YaoPharma Co., Ltd. | 国药准字H20255893 | See source | Category B | XC10AAR069A001020101066 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203479 | See source | Category B | XC10AAR069A001020101397 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113265 | See source | Category B | XC10AAR069A001020101594 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080669 | See source | Category B | XC10AAR069A001020101606 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20247200 | See source | Category B | XC10AAR069A001020101650 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20227079 | See source | Category B | XC10AAR069A001020102763 | NHSA |
| Shanxi Lan Hua Pharma Co., Ltd. romanized | 国药准字H20237182 | See source | Category B | XC10AAR069A001020102909 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | See source | Category B | XC10AAR069A001020102968 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234183 | See source | Category B | XC10AAR069A001020103006 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001020103098 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080242 | See source | Category B | XC10AAR069A001020104010 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20203568 | See source | Category B | XC10AAR069A001020104043 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001020104152 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213616 | See source | Category B | XC10AAR069A001020104565 | NHSA |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20143339 | 20mg | Category B | XC10AAR069A001020104641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20143284 | See source | Category B | XC10AAR069A001020104658 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001020104942 | NHSA |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20203657 | See source | Category B | XC10AAR069A001020106988 | NHSA |
| Anhui Jie Xi Pharmaceuticals Co., Ltd. romanized | 国药准字H20203396 | See source | Category B | XC10AAR069A001020109541 | NHSA |
| Astrazeneca UK limited | 国药准字J20170007 | 20mg | Category B | XC10AAR069A001020110153 | NHSA |
| Astrazeneca UK limited | 国药准字HJ20160545 | See source | Category B | XC10AAR069A001020178241 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001020179303 | NHSA |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20233495 | See source | Category B | XC10AAR069A001020180086 | NHSA |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20213422 | See source | Category B | XC10AAR069A001020181288 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203479 | See source | Category B | XC10AAR069A001020201397 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113265 | See source | Category B | XC10AAR069A001020201594 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080669 | See source | Category B | XC10AAR069A001020201606 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20247200 | See source | Category B | XC10AAR069A001020201650 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20227079 | See source | Category B | XC10AAR069A001020202763 | NHSA |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized | 国药准字H20233536 | See source | Category B | XC10AAR069A001020202968 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234183 | See source | Category B | XC10AAR069A001020203006 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001020203098 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20203568 | See source | Category B | XC10AAR069A001020204043 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001020204152 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213616 | See source | Category B | XC10AAR069A001020204565 | NHSA |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20143339 | 20mg | Category B | XC10AAR069A001020204641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20143284 | See source | Category B | XC10AAR069A001020204658 | NHSA |
| Guangdong Dong Yang Guang Pharma Co., Ltd. romanized | 国药准字H20203657 | See source | Category B | XC10AAR069A001020206988 | NHSA |
| Anhui Jie Xi Pharmaceuticals Co., Ltd. romanized | 国药准字H20203396 | See source | Category B | XC10AAR069A001020209541 | NHSA |
| Astrazeneca UK limited | 国药准字J20170007 | 20mg | Category B | XC10AAR069A001020210153 | NHSA |
| Astrazeneca UK limited | 国药准字HJ20160545 | See source | Category B | XC10AAR069A001020278241 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001020279303 | NHSA |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20213422 | See source | Category B | XC10AAR069A001020281288 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203479 | See source | Category B | XC10AAR069A001020301397 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113265 | See source | Category B | XC10AAR069A001020301594 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080669 | See source | Category B | XC10AAR069A001020301606 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20247200 | See source | Category B | XC10AAR069A001020301650 | NHSA |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | 国药准字H20227079 | See source | Category B | XC10AAR069A001020302763 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234183 | See source | Category B | XC10AAR069A001020303006 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001020303098 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213616 | See source | Category B | XC10AAR069A001020304565 | NHSA |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20143339 | 20mg | Category B | XC10AAR069A001020304641 | NHSA |
| Anhui Jie Xi Pharmaceuticals Co., Ltd. romanized | 国药准字H20203396 | See source | Category B | XC10AAR069A001020309541 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001020379303 | NHSA |
| Shanghai Shang Yao Xin Yi Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20213422 | See source | Category B | XC10AAR069A001020381288 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203479 | See source | Category B | XC10AAR069A001020401397 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20247200 | See source | Category B | XC10AAR069A001020401650 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234183 | See source | Category B | XC10AAR069A001020403006 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001020403098 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213616 | See source | Category B | XC10AAR069A001020404565 | NHSA |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20143339 | 20mg | Category B | XC10AAR069A001020404641 | NHSA |
| Anhui Jie Xi Pharmaceuticals Co., Ltd. romanized | 国药准字H20203396 | See source | Category B | XC10AAR069A001020409541 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001020479303 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203479 | See source | Category B | XC10AAR069A001020501397 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001020503098 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001020579303 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203479 | See source | Category B | XC10AAR069A001020601397 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001020603098 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001020679303 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001020703098 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001020779303 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001020803098 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001020879303 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001020903098 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001020979303 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001021003098 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001021079303 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001021103098 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001021179303 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001021203098 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001021279303 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001021303098 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001021379303 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001021403098 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20223160 | See source | Category B | XC10AAR069A001021503098 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203480 | See source | Category B | XC10AAR069A001030101397 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113246 | See source | Category B | XC10AAR069A001030101594 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | See source | Category B | XC10AAR069A001030101606 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001030103006 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080240 | See source | Category B | XC10AAR069A001030104010 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20203568 | See source | Category B | XC10AAR069A001030104043 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001030104152 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213617 | See source | Category B | XC10AAR069A001030104565 | NHSA |
| Han Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20143337 | 5mg | Category B | XC10AAR069A001030104641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | See source | Category B | XC10AAR069A001030104658 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001030104942 | NHSA |
| Astrazeneca UK limited | 国药准字J20170009 | 5mg | Category B | XC10AAR069A001030110153 | NHSA |
| Astrazeneca UK limited | 国药准字HJ20160611 | See source | Category B | XC10AAR069A001030178241 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001030179303 | NHSA |
| Tian Di Heng Yi Pharmaceutical Co., Ltd. romanized | 国药准字H20233494 | See source | Category B | XC10AAR069A001030180086 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20203480 | See source | Category B | XC10AAR069A001030201397 | NHSA |
| Xian Sheng Pharma Co., Ltd. romanized | 国药准字H20113246 | See source | Category B | XC10AAR069A001030201594 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080240 | See source | Category B | XC10AAR069A001030204010 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001030204152 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213617 | See source | Category B | XC10AAR069A001030204565 | NHSA |
| Han Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20143337 | 5mg | Category B | XC10AAR069A001030204641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | See source | Category B | XC10AAR069A001030204658 | NHSA |
| Astrazeneca UK limited | 国药准字J20170009 | 5mg | Category B | XC10AAR069A001030210153 | NHSA |
| Astrazeneca UK limited | 国药准字HJ20160611 | See source | Category B | XC10AAR069A001030278241 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001030279303 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080240 | See source | Category B | XC10AAR069A001030304010 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001030304152 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213617 | See source | Category B | XC10AAR069A001030304565 | NHSA |
| Han Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20143337 | 5mg | Category B | XC10AAR069A001030304641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | See source | Category B | XC10AAR069A001030304658 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001030379303 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080240 | See source | Category B | XC10AAR069A001030404010 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001030404152 | NHSA |
| Ningbo Ke Er Kang Mei Nuo Hua Pharma Co., Ltd. romanized | 国药准字H20213617 | See source | Category B | XC10AAR069A001030404565 | NHSA |
| Han Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20143337 | 5mg | Category B | XC10AAR069A001030404641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | See source | Category B | XC10AAR069A001030404658 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001030479303 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001030504152 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | See source | Category B | XC10AAR069A001030504658 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001030604152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001030704152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001030804152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001030904152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001031004152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001031104152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20223163 | See source | Category B | XC10AAR069A001031204152 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001031304942 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001031404942 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001031479303 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001031504942 | NHSA |
| Zhejiang Jiang Bei Pharma Co., Ltd. romanized | 国药准字H20203464 | See source | Category B | XC10AAR069A001031579303 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001031604942 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001031704942 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001031804942 | NHSA |
| Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20213588 | See source | Category B | XC10AAR069A001031904942 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080669 | See source | Category B | XC10AAR069A001040101606 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001040103006 | NHSA |
| Lu Nan Bei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20080240 | See source | Category B | XC10AAR069A001040104010 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20269013 | See source | Category B | XC10AAR069A001040104152 | NHSA |
| Han Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20143338 | 10mg | Category B | XC10AAR069A001040104641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | See source | Category B | XC10AAR069A001040104658 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20269013 | See source | Category B | XC10AAR069A001040204152 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | See source | Category B | XC10AAR069A001040204658 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20269013 | See source | Category B | XC10AAR069A001040304152 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | See source | Category B | XC10AAR069A001040304658 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20269013 | See source | Category B | XC10AAR069A001040404152 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | See source | Category B | XC10AAR069A001040404658 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20269013 | See source | Category B | XC10AAR069A001040504152 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080482 | See source | Category B | XC10AAR069A001040504658 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20269013 | See source | Category B | XC10AAR069A001040604152 | NHSA |
| Rui Yang Pharmaceutical Co., Ltd. romanized | 国药准字H20269013 | See source | Category B | XC10AAR069A001040704152 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20080670 | See source | Category B | XC10AAR069A001050101606 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001050103006 | NHSA |
| Han Hui Pharmaceutical Co., Ltd. romanized | 国药准字H20143337 | 5mg | Category B | XC10AAR069A001050104641 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001050104658 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001050204658 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001050304658 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001060103006 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001060104658 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001060204658 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001060304658 | NHSA |
| ZHEJIANG JINGXIN PHARMACEUTICAL CO.，LTD. | 国药准字H20080483 | See source | Category B | XC10AAR069A001060404658 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001070103006 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001080103006 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001090103006 | NHSA |
| Jilin Tian Heng Pharma Co., Ltd. romanized | 国药准字H20234184 | See source | Category B | XC10AAR069A001100103006 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 18 filings and 9 distinct first applicants.
Generic 15 · Supplement 3
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Zhejiang Nord Pharmaceutical Co., Ltd | CYHS2600588 | Generic | 2026/02/28 | Not stated by source | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | CYHS2600587 | Generic | 2026/02/28 | Not stated by source | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | CYHS2504356 | Generic | 2025/12/23 | Not stated by source | CDE |
| Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized | CYHS2602184 | Generic | 2026/09/02 | Not stated by source | CDE |
| Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized | CYHS2602183 | Generic | 2026/09/02 | Not stated by source | CDE |
| AstraZeneca UK Limited; IPR Pharmaceuticals INCORPORATED | JYHB2600475 | Supplement | 2026/08/17 | Not stated by source | CDE |
| AstraZeneca UK Limited; IPR Pharmaceuticals INCORPORATED | JYHB2600474 | Supplement | 2026/08/17 | Not stated by source | CDE |
| AstraZeneca UK Limited; IPR Pharmaceuticals INCORPORATED | JYHB2600473 | Supplement | 2026/08/17 | Not stated by source | CDE |
| Zhejiang Hua Hai Pharmaceutical Technology Co., Ltd. romanized | CYHS2601632 | Generic | 2026/07/08 | Not stated by source | CDE |
| Zhejiang Hua Hai Pharmaceutical Technology Co., Ltd. romanized | CYHS2601630 | Generic | 2026/07/08 | Not stated by source | CDE |
| Yue Kang Pharma Group Co., Ltd. romanized | CYHS2600798 | Generic | 2026/04/08 | Not stated by source | CDE |
| Shandong Yi Jian Pharma Co., Ltd. romanized | CYHS2600498 | Generic | 2026/02/25 | Not stated by source | CDE |
| Shandong Yi Jian Pharma Co., Ltd. romanized | CYHS2600497 | Generic | 2026/02/25 | Not stated by source | CDE |
| Shanxi Qian Hui Pharma Co., Ltd. romanized | CYHS2600124 | Generic | 2026/01/09 | Not stated by source | CDE |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | CYHS2503808 | Generic | 2025/10/28 | Not stated by source | CDE |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | CYHS2503807 | Generic | 2025/10/28 | Not stated by source | CDE |
| Shanxi Fen He Pharmaceutical Co., Ltd. romanized | CYHS2503591 | Generic | 2025/10/01 | Not stated by source | CDE |
| Shanxi Fen He Pharmaceutical Co., Ltd. romanized | CYHS2503590 | Generic | 2025/10/01 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 10 filings and 6 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Zhejiang Nord Pharmaceutical Co., Ltd | CYHS2600588 | Generic | 2026/02/28 | Not stated by source | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | CYHS2600587 | Generic | 2026/02/28 | Not stated by source | CDE |
| Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized | CYHS2602184 | Generic | 2026/09/02 | Not stated by source | CDE |
| Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized | CYHS2602183 | Generic | 2026/09/02 | Not stated by source | CDE |
| Zhejiang Hua Hai Pharmaceutical Technology Co., Ltd. romanized | CYHS2601632 | Generic | 2026/07/08 | Not stated by source | CDE |
| Zhejiang Hua Hai Pharmaceutical Technology Co., Ltd. romanized | CYHS2601630 | Generic | 2026/07/08 | Not stated by source | CDE |
| Yue Kang Pharma Group Co., Ltd. romanized | CYHS2600798 | Generic | 2026/04/08 | Not stated by source | CDE |
| Shandong Yi Jian Pharma Co., Ltd. romanized | CYHS2600498 | Generic | 2026/02/25 | Not stated by source | CDE |
| Shandong Yi Jian Pharma Co., Ltd. romanized | CYHS2600497 | Generic | 2026/02/25 | Not stated by source | CDE |
| Shanxi Qian Hui Pharma Co., Ltd. romanized | CYHS2600124 | Generic | 2026/01/09 | Not stated by source | CDE |
API registrations
Non-component matches: 31 companies with A status and 1 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 瑞舒伐他汀钙 · No verified English name | Anhui Yue Kang Kai Yue Pharmaceutical Co., Ltd. romanized | Y20240001436 | A | Exact ingredient | 2026/07/27 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Jiangsu Pu Run Biopharmaceuticals Co., Ltd. romanized | Y20240001404 | A | Exact ingredient | 2026/07/27 | CDE |
| 瑞舒伐他汀钙 · No verified English name | M/s. Biocon Limited | Y20240000236 | I | Exact ingredient | 2024/03/21 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Lee Pharma Limited | Y20230000872 | A | Exact ingredient | 2026/03/31 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Zhejiang Jiang Bei Nan Hai Pharma Co., Ltd. romanized | Y20230000714 | A | Exact ingredient | 2025/02/14 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Zhejiang Jiang Bei Pharma Co., Ltd. romanized | Y20220000289 | A | Exact ingredient | 2023/09/27 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Zhejiang Yong Tai Pharma Co., Ltd. romanized | Y20210000962 | A | Exact ingredient | 2023/07/28 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Yun Peng Pharmaceuticals Group Co., Ltd. romanized | Y20210000652 | A | Exact ingredient | 2024/11/28 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Zhejiang Le Pu Pharma Co., Ltd. romanized | Y20210000578 | A | Exact ingredient | 2026/06/16 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Xuan Cheng Mei Nuo Hua Pharma Co., Ltd. romanized | Y20210000329 | A | Exact ingredient | 2022/12/16 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Hanmi Fine Chemical Co., Ltd. | Y20210000135 | A | Exact ingredient | 2024/08/07 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Sun Pharmaceutical Industries Limited | Y20210000168 | A | Exact ingredient | 2024/11/22 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Centrient Pharmaceuticals India Private Limited | Y20210000015 | A | Exact ingredient | 2025/03/15 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Hebei Guang Xiang Pharmaceutical Co., Ltd. romanized | Y20210000024 | A | Exact ingredient | 2026/10/23 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Nan Tong Chang You Pharma Technology Co., Ltd. romanized | Y20200001398 | A | Exact ingredient | 2026/08/08 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Lian Yun Gang Gui Ke Pharma Co., Ltd. romanized | Y20200000654 | A | Exact ingredient | 2026/08/18 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Topfond Pharmaceutical Co., Ltd. | Y20190000845 | A | Exact ingredient | 2026/07/17 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Hunan Jiu Dian Hong Yang Pharmaceutical Co., Ltd. romanized | Y20190021369 | A | Exact ingredient | 2025/11/18 | CDE |
| 瑞舒伐他汀钙 · No verified English name | MSN Laboratories Private Limited | Y20190000940 | A | Exact ingredient | 2025/05/24 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | Y20190009618 | A | Exact ingredient | — | CDE |
| 瑞舒伐他汀钙 · No verified English name | Shao Xing Jing Xin Pharma Co., Ltd. romanized | Y20190009351 | A | Exact ingredient | 2024/02/08 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Zhejiang Hai Zheng Pharma Co., Ltd. romanized | Y20190007514 | A | Exact ingredient | 2023/11/29 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Lian Yun Gang Run Zhong Pharmaceutical Co., Ltd. romanized | Y20190007277 | A | Exact ingredient | — | CDE |
| 瑞舒伐他汀钙 · No verified English name | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Y20190007037 | A | Exact ingredient | 2022/10/28 | CDE |
| 瑞舒伐他汀钙 · No verified English name | CSPC OUYI PHARMACEUTICAL CO., LTD. | Y20190007022 | A | Exact ingredient | — | CDE |
| 瑞舒伐他汀钙 · No verified English name | KRKA, d.d., Novo mesto | Y20180001608 | A | Exact ingredient | 2023/08/14 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Xian Sheng Pharma Co., Ltd. romanized | Y20190000761 | A | Exact ingredient | 2025/08/14 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Zhejiang Mei Nuo Hua Drug Chemical Co., Ltd. romanized | Y20190000565 | A | Exact ingredient | 2026/04/13 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Ru Yuan Dong Yang Guang Pharma Co., Ltd. romanized | Y20180001564 | A | Exact ingredient | 2026/04/22 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Shao Xing Jing Xin Pharma Co., Ltd. romanized | Y20180000877 | A | Exact ingredient | — | CDE |
| 瑞舒伐他汀钙 · No verified English name | Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized | Y20170001976 | A | Exact ingredient | 2024/08/07 | CDE |
| 瑞舒伐他汀钙 · No verified English name | AstraZeneca UK Limited | Y20170001705 | A | Exact ingredient | 2023/08/23 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Zhejiang Jiang Bei Pharma Co., Ltd. romanized | Y20170001629 | A | Exact ingredient | 2024/05/01 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Nanjing You Ke Pharmaceutical Co., Ltd. romanized | Y20170001088 | A | Exact ingredient | 2025/12/03 | CDE |
| 瑞舒伐他汀钙 · No verified English name | Changzhou Pharmaceutical Factory Co., Ltd. romanized | Y20170000215 | A | Exact ingredient | 2024/03/14 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/10/19Supplement delivery
A Si Li Kang Investment (Zhongguo) Co., Ltd. romanized
JYHB2600323
Fact date: 2026/10/19 · Publication date: 2026/10/20 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 25 ↗ -
2026/10/19Supplement delivery
A Si Li Kang Investment (Zhongguo) Co., Ltd. romanized
JYHB2600322
Fact date: 2026/10/19 · Publication date: 2026/10/20 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 24 ↗ -
2026/10/19Supplement delivery
A Si Li Kang Investment (Zhongguo) Co., Ltd. romanized
JYHB2600321
Fact date: 2026/10/19 · Publication date: 2026/10/20 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 23 ↗ -
2026/09/02Accepted
Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized
CYHS2602184
Fact date: 2026/09/02 · Site observation date: 2026/10/21
View source ↗ -
2026/09/02Accepted
Jiangsu Ou Ge Pharmaceutical Co., Ltd. romanized
CYHS2602183
Fact date: 2026/09/02 · Site observation date: 2026/10/21
View source ↗ -
2026/08/17Accepted
AstraZeneca UK Limited; IPR Pharmaceuticals INCORPORATED
JYHB2600475
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗ -
2026/08/17Accepted
AstraZeneca UK Limited; IPR Pharmaceuticals INCORPORATED
JYHB2600474
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗ -
2026/08/17Accepted
AstraZeneca UK Limited; IPR Pharmaceuticals INCORPORATED
JYHB2600473
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Rosuvastatin Calcium Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy